Lamb Weston Shares Face Diverging Views Ahead of Earnings

As frozen potato specialist Lamb Weston prepares to release its quarterly results in late September, market participants appear deeply divided. Major institutional investors are placing contradictory bets, while equity researchers hold conflicting views on the stock’s valuation. The upcoming earnings report may determine whether the company is poised for a rebound or faces further headwinds.

Conflicting Signals from Major Investors

Institutional activity reveals a stark lack of consensus around Lamb Weston’s near-term prospects. Recent regulatory filings show that Scientech Research and MBB Public Markets established new multimillion-dollar positions in the company. In contrast, European asset manager Amundi sharply reduced its exposure, slashing its holdings by more than 85%. These opposing moves underscore significant uncertainty among sophisticated market players.

Analysts Divided on Fair Value

Equity researchers have issued markedly different assessments of the company’s outlook. Barclays recently raised its price target to $68, expressing a bullish stance. On the other side, Bank of America maintained a more cautious position with a $56 target. This wide discrepancy reflects broader concerns about volatile input costs and shifting consumer behavior in the food sector.

Previous Quarter Outperformance

Lamb Weston’s most recent quarterly update in May exceeded expectations. The company reported adjusted earnings per share of $0.87, significantly surpassing the $0.64 consensus estimate. Revenue reached $1.68 billion, also beating forecasts, driven by impressive global volume growth of 8%.

Should investors sell immediately? Or is it worth buying Lamb Weston?

Strategic Cost-Cutting Initiative

In response to market pressures, management has implemented a comprehensive efficiency program dubbed “Focus to Win.” The strategy includes reducing global headcount by approximately 4% and aims to deliver at least $250 million in savings by fiscal 2028. This initiative signals management’s commitment to streamlining operations and improving profitability amid challenging conditions.

Upcoming Report Pivotal for Direction

All attention now turns to the quarterly report expected on September 30. Investors will scrutinize whether the strategic restructuring is already yielding positive results and if the company can maintain its full-year guidance. Management has projected net sales between $6.35 billion and $6.55 billion, with adjusted EBITDA anticipated in the range of $1.0 billion to $1.2 billion.

The upcoming earnings release will test whether Lamb Weston’s efficiency measures and attractive 2.6% dividend yield can win over skeptical investors—or confirm the concerns of those anticipating further challenges.